/People

Marc Semigran

Investor

Clinical Advisory Board at Broadview Ventures

Boston, Massachusetts, United States

Find your path to Marc

371 people in our graph can introduce you to Marc.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Thomas Needham to introduce you to Marc

You →Thomas · together at Renovacor (2021–2022) →Marc

Ask Jamie Chen to introduce you to Marc

You →Jamie · together at Renovacor →Marc

Ask Sam Okafor to introduce you to Marc

You →Sam · 3 people · together at Edgewise Therapeutics →Marc

Sign up to find every way you can get introduced to Marc

  • Your email: the people you already email who know Marc
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Marc
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Chief Development Officer of Edgewise Therapeutics with extensive clinical development and translational medicine experience, previously CMO at Renovacor and MyoKardia and former head of the MGH Heart Failure and Cardiac Transplant Program. He serves on Broadview's Clinical Advisory Board.

Experience

  1. Semigran ConsultingConsultant and Board Membercurrent2025 — present
  2. Edgewise TherapeuticsChief Development Officer (CDO)2022 — 2025Boston, Massachusetts, United States
  3. RenovacorChief Medical Officer2021 — 2022Cambridge, Massachusetts, United States & Philadelphia, PA
  4. MyoKardiaSenior Vice President, Medical Sciences2019 — 2021South San Francisco, CA
  5. MyoKardiaChief Medical Officer2016 — 2019South San Francisco
  6. Harvard Medical SchoolAssociate Professor2008 — 2017Greater Boston
  7. Massachusetts General Hospital/Harvard Medical SchoolMedical Director, Heart Failure and Cardiac Transplantation2004 — 2016Greater Boston

Skills & more

Medicine3Heart Failure4Transplant3Customer Service1Healthcare1Research1HospitalsPublic Speaking1Microsoft WordPowerPoint

From Marc's professional profile.

Colleagues at Broadview Ventures

Frequently asked questions

Who is Marc Semigran?
Chief Development Officer of Edgewise Therapeutics with extensive clinical development and translational medicine experience, previously CMO at Renovacor and MyoKardia and former head of the MGH Heart Failure and Cardiac Transplant Program. He serves on Broadview's Clinical Advisory Board.
Where does Marc Semigran work?
Marc Semigran is Clinical Advisory Board at Broadview Ventures.
Where did Marc Semigran go to school?
Marc Semigran studied at Harvard Medical School (Doctor of Medicine (M.D.), Medicine); Harvard University (Bachelor’s Degree, Chemistry).

Same school

Shared employers